01—Abstract
Summary
Summary of the 10-K filed February 22, 2017. Cited figures are marked; the original filing is the authoritative source.
Elevance Health, Inc. (formerly Anthem, Inc.) reported strong revenue growth in 2016, driven by increases in both its Government and Commercial/Specialty segments.
The company highlighted a significant rise in Medicaid membership and sustained growth in National Accounts. Despite overall revenue gains, net income saw a slight decline due to increased transaction costs related to the pending acquisition of Cigna, higher interest expenses, and reduced net earnings from investments.
The company's financial performance was significantly impacted by the ongoing legal and regulatory challenges surrounding the proposed Cigna merger, which introduced considerable uncertainty and transaction-related expenses. Elevance Health remains focused on its strategy of organic growth, strategic acquisitions, and efficient capital utilization, while navigating the evolving healthcare landscape influenced by regulatory changes and market dynamics.
02—Key points
Key Highlights
- Total operating revenue increased by 7.4% to $84.2 billion in 2016, primarily driven by growth in Government and Commercial/Specialty segments.
- Medicaid membership saw substantial growth of 10.4%, contributing significantly to the Government Business segment's revenue increase.
- Net income decreased by 3.5% to $2.5 billion in 2016, impacted by transaction costs related to the Cigna acquisition and other operational factors.
- The company is actively engaged in litigation concerning its proposed acquisition of Cigna, which is subject to regulatory approvals and significant legal challenges.
- Elevance Health continues to invest in care management programs and adapt its product offerings to comply with the evolving healthcare landscape, including the Affordable Care Act (ACA).
- The company ended the year with a strong liquidity position, though it is navigating potential impacts from its significant debt associated with the Cigna acquisition.
03—One dollar
04—Financials
Financial Highlights
Figures from 10-KFY2016filed February 22, 2017Financial Statements
FY2016 against FY2015
| Line item | FY2016FY2015 | Change |
|---|---|---|
| Revenue | $84.86B$79.16B | +7.2% |
| SG&A Expenses | $12.56B$12.53B | +0.2% |
| Operating Income | $4.80B$4.75B | +1.0% |
| Interest Expense | $723.00M$653.00M | +10.7% |
| Net Income | $2.47B$2.56B | −3.5% |
| EPS (Basic) | $9.39$9.73 | −3.5% |
| EPS (Diluted) | $9.21$9.38 | −1.8% |
| Shares Outstanding (Basic) | 262.90M263.00M | 0.0% |
| Shares Outstanding (Diluted) | 268.10M272.90M | −1.8% |
05—Questions
Frequently Asked Questions
What was the overall financial performance of Elevance Health in 2016?
In 2016, Elevance Health experienced a 7.4% increase in total operating revenue, reaching $84.2 billion, driven by growth across its Government and Commercial/Specialty segments, particularly in Medicaid membership. However, net income saw a slight decrease of 3.5% to $2.5 billion due to factors including increased transaction costs associated with the pending Cigna acquisition, higher interest expenses, and reduced investment earnings.
What are the major risks and uncertainties facing Elevance Health as outlined in the filing?
Key risks and uncertainties include the outcome of the pending Cigna acquisition, which faces significant regulatory and legal challenges; potential impacts of changes to the Patient Protection and Affordable Care Act (ACA); the company's ability to manage healthcare costs and effectively price its products, especially in the volatile public exchange markets; potential government regulatory changes affecting Medicare and Medicaid programs; and cybersecurity risks, as evidenced by a reported cyber attack in early 2015.
How is Elevance Health navigating the regulatory environment, particularly concerning the ACA?
Elevance Health is actively managing the complexities introduced by the ACA, which has led to new growth opportunities as well as regulatory challenges. The company has adapted its product designs, pricing strategies, and administrative processes to comply with ACA requirements, including provisions on guaranteed coverage, benefit mandates, minimum loss ratios, and public exchanges. However, the potential for future modifications or repeal of the ACA introduces ongoing uncertainty.
What is the status of the proposed acquisition of Cigna?
In July 2015, Elevance Health announced its agreement to acquire Cigna for approximately $53 billion. However, the acquisition faced significant regulatory opposition, with the U.S. Department of Justice filing a lawsuit to block it. In early 2017, a district court ruled in favor of the DOJ. Both Elevance Health and Cigna initiated litigation against each other regarding the merger agreement. Elevance Health is appealing the district court's decision and remains committed to completing the acquisition, though significant legal and regulatory hurdles remain.
06—Continue